HI SB2751

Defines "compounded prescription drug" for workers' compensation purposes as drugs compounded in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a)

Limits physician dispensing of prescription drugs to 30 days following an industrial injury, after which all prescriptions must be obtained through the employer's pharmacy benefit manager

Requires non-FDA-approved drugs such as compounded medications to be identified as compounds on treatment plans and bills, supported by a statement of medical necessity explaining why an FDA-approved alternative is unsuitable

Failure to properly identify a compound drug on treatment plans or billing makes the drug non-reimbursable

Effective date: January 1, 2077